What is the ticker symbol for Jupiter Neurosciences?

Jupiter Neurosciences trades under the ticker JUNS on NASDAQ.

What sector does Jupiter Neurosciences operate in?

Jupiter Neurosciences is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze JUNS in a portfolio?

PortView shows JUNS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Jupiter Neurosciences (JUNS) Stock Analysis

NASDAQHealthcareBiotechnology

$2.62-0.76%

1-year price historyRange $2.42 – $127.50

52-week range$2.62

$2.25$127.50

Track JUNS in your portfolio for free · Portfolio tracker

What Jupiter Neurosciences does

Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main objective of addressing neuro-inflammation. The company's pipeline includes several drug candidates: JNS101 is undergoing Phase II trials for Friedreich's Ataxia, a rare neurological disorder that damages the nervous system and causes mobility issues. Also in Phase II, JNS102 is being developed for mucopolysaccharidosis Type I, JNS107 for MELAS Syndrome, and JNS108 for mild cognitive impairment and early Alzheimer's disease. Furthermore, the company is progressing JNS109 for amyotrophic lateral sclerosis, JNS110 for traumatic brain injury and concussion, and JNS120 as a treatment for COVID-19. Founded in 2016, the company, formerly known as Jupiter Orphan Therapeutics, Inc., adopted its current name in August 2021 and is headquartered in Jupiter, Florida.

Key metrics

Market cap

$3.45M

P/E (TTM)

-0.13

EPS (TTM)

$-20.31

Beta

1.88

Dividend yield

0.00%

Revenue / share

$0.12

50-day avg

$3.33

200-day avg

$21.56

52-week high

$127.50

52-week low

$2.25

CEO

Christer Rosen

ETFs linked to JUNS

Broad-market and Healthcare sector ETFs an investor holding Jupiter Neurosciences is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how JUNS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze JUNS in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Jupiter Neurosciences?: Jupiter Neurosciences trades under the ticker JUNS on NASDAQ.
Which exchange is JUNS listed on?: JUNS is listed on NASDAQ.
What sector does Jupiter Neurosciences operate in?: Jupiter Neurosciences is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze JUNS in a portfolio?: PortView shows JUNS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.